FORM 10-Q

                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549


   X    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
- ------
        EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JANUARY 27, 2001.

______  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
        EXCHANGE ACT OF 1934.


                          Commission File No. 0-20572

                           PATTERSON DENTAL COMPANY
                           ------------------------
            (Exact Name of Registrant as Specified in its Charter)


                 Minnesota                            41-0886515
                 ---------                            ----------
          (State of Incorporation)         (IRS Employer Identification No.)


             1031 Mendota Heights Road, St. Paul, Minnesota 55120
             ----------------------------------------------------
                   (Address of Principal Executive Offices)
                                  (Zip Code)


                                (651) 686-1600
                                --------------
             (Registrant's Telephone Number, Including Area Code)


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for at least the past 90 days.

             X    Yes                      _______ No
          ------


Patterson Dental Company has outstanding 67,516,945 shares of common stock as of
March 8, 2001.

                                 Page 1 of 14


                           PATTERSON DENTAL COMPANY

                                     INDEX




                                                                                                             Page
                                                                                                             ----
                                                                                                          
PART I - FINANCIAL INFORMATION

     Item 1 - Financial Statements                                                                            3-7

              Consolidated Balance Sheets as of January 27, 2001 and April 29, 2000                             3

              Condensed Consolidated Statements of Income for the Three and Nine
              Months Ended January 27, 2001 and January 29, 2000                                                4

              Condensed Consolidated Statements of Cash Flows for the Nine
              Months Ended January 27, 2001 and January 29, 2000                                                5

              Notes to Consolidated Financial Statements                                                        6

     Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations.         8-11

     Item 3 - Quantitative and Qualitative Disclosures About Market Risk                                       12

PART II - OTHER INFORMATION

     Item 6 - Exhibits and Reports on Form 8-K                                                                 13

     Signatures                                                                                                14




Safe Harbor Statement Under The Private Securities Litigation Reform Act Of
- ---------------------------------------------------------------------------
1995:
- ----

     This Form 10-Q for the period ended January 27, 2001, contains certain
forward-looking statements as defined in the Private Securities Litigation
Reform Act of 1995, which may be identified by the use of forward-looking
terminology such as "may", "will", "expect", "anticipate", "estimate",
"believe", "goal", or "continue", or comparable terminology that involves risks
and uncertainties and that are qualified in their entirety by cautionary
language set forth in the Company's Form 10-K report filed July 25, 2000, and
other documents filed with the Securities and Exchange Commission. See also
pages 11-12 of this Form 10-Q.

                                       2


                         PART I FINANCIAL INFORMATION

                           PATTERSON DENTAL COMPANY
                          CONSOLIDATED BALANCE SHEETS
                            (Dollars in thousands)



                                                                            Jan. 27, 2001        Apr. 29, 2000
                                                                         ------------------     ---------------
ASSETS                                                                     (unaudited)
                                                                                          
Current assets:
      Cash and cash equivalents                                            $     141,379          $    113,453
      Short-term investments                                                      16,266                 4,720
      Receivables, net                                                           134,708               132,419
      Inventory                                                                  110,887                92,838
      Prepaid expenses and other current assets                                    8,851                 7,978
                                                                         ----------------       ---------------
         Total current assets                                                    412,091               351,408
Property and equipment, net                                                       47,953                46,022
Intangibles, net                                                                  50,786                50,730
Other                                                                              5,054                 3,816
                                                                         ----------------       ---------------
         Total assets                                                      $     515,884          $    451,976
                                                                         ================       ===============

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
      Accounts payable                                                     $      80,399          $     80,097
      Accrued payroll expense                                                     17,561                15,194
      Income taxes payable                                                         3,388                 1,110
      Other accrued expenses                                                      20,376                16,505
                                                                         ----------------       ---------------
         Total current liabilities                                               121,724               112,906
Non-current liabilities                                                            3,166                 3,458
                                                                         ----------------       ---------------
         Total liabilities                                                       124,890               116,364

Deferred credits                                                                   4,478                 5,142

STOCKHOLDERS' EQUITY
      Preferred stock                                                                ---                   ---
      Common stock                                                                   675                   674
      Additional paid-in capital                                                  68,039                67,022
      Accumulated other comprehensive loss                                        (2,478)               (2,060)
      Retained earnings                                                          333,342               277,896
      Note receivable from ESOP                                                  (13,062)              (13,062)
                                                                         ----------------       ---------------
         Total stockholders' equity                                              386,516               330,470
                                                                         ----------------       ---------------
         Total liabilities and stockholders' equity                        $     515,884          $    451,976
                                                                         ================       ===============


                            See accompanying notes.

                                       3


                           PATTERSON DENTAL COMPANY
                  CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands except per share amounts)
                                  (Unaudited)



                                                  Three Months Ended                      Nine Months Ended
                                            Jan. 27, 2001      Jan. 29, 2000        Jan. 27, 2001      Jan. 29, 2000
                                                                                      (39 weeks)         (40 weeks)
                                            -------------      -------------        -------------      -------------
                                                                                           
Net sales                                      $  288,890         $  260,172           $  846,056         $  763,206

Cost of sales                                     180,374            163,756              534,632            482,470
                                               ----------         ----------           ----------         ----------

Margin                                            108,516             96,416              311,424            280,736

Operating expenses                                 77,913             70,445              227,841            210,313
                                               ----------         ----------           ----------         ----------

Operating income                                   30,603             25,971               83,583             70,423

Other income and expense:
     Amortization of deferred credits                 217                222                  664                664
     Finance income, net                            1,796              1,285                4,541              3,325
     Interest expense                                 (41)               (37)                 (98)              (139)
     Profit (loss) on currency exchange                 7                 31                 (109)                (5)
                                               ----------         ----------           ----------         ----------

Income before income taxes                         32,582             27,472               88,581             74,268

Income taxes                                       12,196             10,280               33,132             27,776
                                               ----------         ----------           ----------         ----------
Net income                                     $   20,386         $   17,192           $   55,449         $   46,492
                                               ==========         ==========           ==========         ==========

Earnings per share - basic and diluted         $     0.30         $     0.25           $     0.82         $     0.69
                                               ==========         ==========           ==========         ==========

Weighted average common and dilutive
     potential common shares                       67,863             67,593               67,728             67,567
                                               ==========         ==========           ==========         ==========


                            See accompanying notes.

                                       4


                           PATTERSON DENTAL COMPANY
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                            (Dollars in thousands)
                                  (Unaudited)



                                                                                   Nine Months Ended
                                                                          Jan. 27, 2001        Jan. 29, 2000
                                                                            (39 weeks)           (40 weeks)
                                                                          --------------      --------------
                                                                                        
Operating activities:
      Net income                                                            $   55,449           $   46,492
      Adjustments to reconcile net income to net cash provided by
      operating activities:
            Depreciation                                                         5,757                5,030
            Amortization of deferrals                                             (664)                (664)
            Amortization of goodwill                                             2,467                2,236
            Bad debt expense                                                       627                  890
            Change in assets and liabilities, net of acquired                  (14,673)             (12,372)
                                                                            ----------           ----------
Net cash provided by operating activities                                       48,963               41,612

Investing activities:
      Additions to property and equipment, net                                  (7,276)             (12,700)
      Acquisitions, net                                                         (2,627)              (2,842)
      Purchase of short-term investments                                       (11,546)              (6,662)
      Investment in equipment contracts                                           ----              (14,940)
                                                                            ----------           ----------
 Net cash used in investing activities                                         (21,449)             (37,144)

Financing activities:
      Payments and retirement of long-term debt and obligations under
        capital leases                                                            (546)                (457)
      Common stock issued, net                                                   1,013               (1,016)
                                                                            ----------           ----------
Net cash provided by (used in) financing activities                                467               (1,473)

Effect of exchange rate changes on cash                                            (55)                 130
                                                                            ----------           ----------
Net increase in cash and cash equivalents                                       27,926                3,125

Cash and cash equivalents at beginning of period                               113,453               78,746
                                                                            ----------           ----------
Cash and cash equivalents at end of period                                  $  141,379           $   81,871
                                                                            ==========           ==========


                            See accompanying notes.

                                       5


                           PATTERSON DENTAL COMPANY
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                 (Dollars in thousands except per share data)
                                  (Unaudited)
                               January 27, 2001

1.   In the opinion of management, the accompanying unaudited condensed
     consolidated financial statements contain all adjustments necessary to
     present fairly the financial position of the Company as of January 27,
     2001, and the results of operations and the cash flows for the periods
     ended January 27, 2001 and January 29, 2000. Such adjustments are of a
     normal recurring nature. The results of operations for the quarter ended
     January 27, 2001 and January 29, 2000, are not necessarily indicative of
     the results to be expected for the full year. The balance sheet at April
     29, 2000, is derived from the audited balance sheet as of that date. These
     financial statements should be read in conjunction with the financial
     statements included in the 2000 Annual Report on Form 10-K filed on July
     25, 2000.

2.   The fiscal year end of the Company is the last Saturday in April. The third
     quarter of fiscal year 2001 and 2000 represent the 13 weeks ended January
     27, 2001 and January 29, 2000, respectively. The first nine months of
     fiscal year 2001 include 39 weeks while the first nine months of fiscal
     year 2000 include 40 weeks.

3.   Total comprehensive income was $20,771 and $55,031 for the three and nine
     months ended January 27, 2001, respectively, and $17,625 and $47,275 for
     the three and nine months ended January 29, 2000, respectively.

4.   On June 13, 2000 the Company declared a two-for-one stock split in the form
     of a 100% stock dividend payable July 21, 2000, to shareholders of record
     on June 30, 2000. All references in the financial statements and related
     notes to weighted average shares outstanding, share issuances, related
     prices and per share amounts have been restated to reflect the split.

                                       6


5.   The following table sets forth the denominator for the computation of basic
     and diluted earnings per share:




                                                          Three Months Ended                 Nine Months Ended
                                                      --------------------------        ------------------------
                                                       Jan. 27,          Jan. 29,       Jan. 27,        Jan. 29,
                                                         2001             2000            2001            2000
                                                      ---------         --------        --------        --------
                                                                                            
Denominator:
  Denominator for basic earnings per
   share - weighted-average shares                      67,454           67,373            67,410          67,344

  Effect of dilutive securities:
    Stock Option Plans                                     310              123               219             122
    Employee Stock Purchase Plan                            10                9                11              10
    Capital Accumulation Plan                               89               88                88              91
                                                      --------        ---------         ---------       ---------

  Dilutive potential common shares                         409              220               318             223
                                                      --------        ---------         ---------       ---------

  Denominator for diluted earnings per
    share - adjusted weighted-average
    shares and assumed conversions                      67,863           67,593            67,728          67,567
                                                      ========        =========         =========       =========



6.  In September 2000, the Emerging Issues Task Force reached a consensus on
    Issue No. 00-10, "Accounting for Shipping and Handling Fees and Costs"
    (Issue 00-10), which is required to be applied no later than the Company's
    fiscal fourth quarter. The Issue requires companies to classify as revenue
    all amounts related to shipping and handling that are billed to a customer
    in a sale transaction. If shipping or handling costs are significant and are
    not included in cost of sales, companies must disclose both the amount of
    such costs and the line item on the income statement where such costs are
    reported. Historically the Company has reported the net cost of its shipping
    and handling activities as an operating expense. The consensus of this Issue
    will probably result in some reclassifications within the structure of the
    Company's operating statement thus revising certain operating ratios. These
    potential reclassifications will have no impact on reported earnings.
    Management is continuing to review the impact of Issue 00-10 on the
    Company's financial statements and the options available, but has formed no
    definitive opinion as to how it will implement the standard.

                                       7


                    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS


     RESULTS OF OPERATIONS

     The following table sets forth, for the periods indicated, the percentage
     of net sales represented by certain operational data.


                                         Three Months Ended  Nine Months Ended
                                         ------------------  -----------------
                                         Jan. 27,  Jan. 29,  Jan. 27,  Jan. 29,
                                           2001     2000       2001       2000
                                          ------   ------     ------     -----

     Net sales..........................   100.0%   100.0%     100.0%    100.0%
     Cost of sales......................    62.4%    62.9%      63.2%     63.2%
                                          ------   ------     ------     -----

     Gross profit.......................    37.6%    37.1%      36.8%     36.8%
     Operating expenses.................    27.0%    27.1%      26.9%     27.6%
                                          ------   ------     ------     -----

     Operating income...................    10.6%    10.0%       9.9%      9.2%
     Other income and expense, net......     0.7%     0.6%       0.6%      0.5%
                                          ------   ------     ------     -----

     Income before income taxes.........    11.3%    10.6%      10.5%      9.7%
     Income taxes.......................     4.2%     4.0%       3.9%      3.6%
                                          ------   ------     ------     -----

     Net income.........................     7.1%     6.6%       6.6%      6.1%
                                          ======   ======     ======     =====


     QUARTER ENDED JANUARY 27, 2001 COMPARED TO QUARTER ENDED JANUARY 29, 2000.

          Net Sales. Net sales for the three months ended January 27, 2001
     ("Current Quarter") totaled $288.9 million up 11% from $260.2 million for
     the three months ended January 29, 2000 ("Prior Quarter"). Sales of
     consumable dental supplies, including printed office products, increased
     9.1% to $175.8 million led by an 11.5% increase in the U.S. dental market.
     A 2.5% decline in printed office product sales and a nominal increase in
     the Canadian market tempered consumable dental supply sales in the current
     quarter. Dental equipment and software sales totaled $90.6 million in the
     Current Quarter versus $80.1 million in the Prior Quarter. Double-digit
     increases in most equipment product offerings drove the 13.1% increase in
     dental equipment and software sales. Equipment sales growth in the Current
     Quarter slowed in comparison to the first half of the year primarily in
     new-generation dental equipment lines. In addition, equipment sales in
     Canada were down 10.3% quarter over quarter. Sales of clinical software
     grew with digital equipment, but total software unit sales were flat in the
     Current Quarter due to reduced sales of front-office practice management
     software. Sales of other products and services, consisting of parts,
     technical service, software support and insurance e-claims, grew 18.9% to
     $22.5 million.

                                       8


          Gross Margin. Gross margins increased $12.1 million or 12.5% over the
     Prior Quarter due to increased sales volumes and an improvement in the
     gross margin rate to 37.6% in the Current Quarter from 37.1% in the Prior
     Quarter. The 50 basis point increase in the gross margin rate reflects
     better margins at the point-of-sale, changes in product mix and an increase
     in vendor incentives.

          Operating Expenses. Operating expenses were $77.9 million in the
     Current Quarter, 10.6% higher than the Prior Quarter, but relatively
     unchanged as a percent of sales at 27.0% in the Current Quarter versus
     27.1% for the Prior Quarter. The flat expense rate reflects the benefit of
     improved operating leverage and cost containment efforts offset by the
     negative impact of higher commission expense resulting from the Company's
     margin based commission programs.

          Operating Income. Operating income increased 17.8% to $30.6 million
     for the Current Quarter from $26.0 million for the Prior Quarter. Operating
     income increased as a percent of net sales from 10.0% to 10.6% due
     principally to an improved gross margin rate.

          Other Income. Other income, net of expenses, was $2.0 million for the
     Current Quarter compared to $1.5 million for the Prior Quarter. Other
     income increased due to higher average short-term investments of cash.

          Income Taxes. The effective income tax rate at 37.4% remained the same
     as last year.

          Net Income.  Net income increased to $20.4 million, or 18.6% due to
     the factors discussed above.

          Earnings Per Share. Diluted earnings per share increased to $0.30
     versus $0.25 reported a year ago, a 5 cent or 20.0% increase over the same
     quarter a year ago.

NINE MONTHS ENDED JANUARY 27, 2001 COMPARED TO NINE MONTHS ENDED JANUARY 29,
2000.

          Net Sales. Net sales increased 10.9% to $846.1 million for the nine
     months ended January 27, 2001 ("Current Period") from $763.2 million for
     the nine months ended January 29, 2000 ("Prior Period"). The Current Period
     includes 39 weeks versus 40 weeks in the Prior Period. Excluding the impact
     of the additional week, sales increased approximately 14%. Sales references
     in parentheses exclude the additional week. Acquisitions contributed 3
     percentage points, or approximately $20 million, to the overall sales
     growth. Sales of consumable dental supplies, including printed office
     products, increased 7.9%(11%) due primarily to contributions from an
     expanded sales force. The printed office products business closed several
     sales locations and experienced turnover in its direct sales force in this
     year's first quarter resulting in a year-to-date decline in sales of
     4.4%(2%). Dental equipment and software sales increased 17.1%(20%) due to
     strong demand across the equipment product lines. Equipment and software
     sales were negatively impacted by the Company's software business, which
     faced a difficult sales comparison with the year-earlier period. Sales of
     other services and products increased 13.2%(16%) in the current period due
     mostly to increases in technical services and parts.

                                       9


          Gross Margin. Gross margins increased $30.7 million to $311.4 million
     for the Current Period due solely to the increase in sales volumes.
     Year-to-date gross margins amounted to 36.8% of sales, the same as last
     year. Although margins improved in the second and third quarters, the
     increase was not sufficient to offset the mix related margin decline
     experienced in the first quarter due to lower software and software related
     service sales as a percent of total sales.

          Operating Expenses. Operating expenses increased 8.3% to $227.8
     million for the Current Period from $210.3 million for the Prior Period.
     The increase in operating expenses was related to greater sales volume. The
     Company gained efficiencies from its infrastructure and controlled costs
     resulting in a 70 basis point reduction in the operating expense rate which
     declined from 27.6% in the Prior Period to 26.9% in the Current Period.

          Operating Income. Operating income increased 18.7% to $83.6 million
     for the Current Period from $70.4 million for the Prior Period. Operating
     income, which increased as a percent of net sales from 9.2% to 9.9%,
     benefited from a reduction in operating costs and improved operating
     leverage.

          Other Income. Other income, net of expenses, was $5.0 million for the
     Current Period compared to $3.8 million for the Prior Period. Increased
     average short-term investments of cash and higher finance income from long-
     term contracts resulted in the $1.2 million increase in other income.

          Income Taxes. The effective income tax rate at 37.4% remained the same
     as last year.

          Net Income. Net income was $55.4 million, up $8.9 million or 19.3%
     from $46.5 million reported in the first nine-months of last year due to
     the factors discussed above.

          Earnings Per Share. Earnings per share were $0.82 which represents a
     13 cent or 18.8% increase over the same period a year ago.

LIQUIDITY AND CAPITAL RESOURCES

     Our financial condition remains strong. Cash generated from operating
     activities was our principal source of funds during the nine months ended
     January 27, 2001 and was used primarily to invest in working capital, fund
     capital expenditures and make acquisitions.

     Operating activities generated cash of $49.0 million in the first nine
     months of 2001, compared to the same period in 2000 where operating
     activities provided cash of $41.6 million. The increase of $7.4 million was
     due primarily to a 19.3% increase in net income.

     Capital expenditures for the first nine months of 2001 declined $5.4
     million from the prior year period when the Company was funding the
     construction of a new distribution center.

     For the nine months ended January 27, 2001 the Company invested $2.6
     million to acquire one dental distribution business and eCheck-Up.com, a
     newly developed Internet service that will provide on-line payroll, human
     resources and payables processing through its web site. In comparison, the
     Company spent $2.8 million in the prior year period to acquire two dental
     distribution businesses.

                                       10


     In September 1999, the Board of Directors authorized the repurchase of up
     to two million shares of our common stock. For the nine months ended
     January 27, 2001, the Company repurchased 75,000 shares for $2.1 million.

     The investment in equipment contracts resulted from the decision to hold,
     as opposed to sell, $20.1 million of equipment contracts receivable in the
     third quarter of 2000, $14.9 million of which was classified as a long-term
     asset on the balance sheet.

     Available liquid resources at January 27, 2001 consisted of $157.6 million
     of cash and short-term investments and $28.3 million available under
     existing bank lines. The Company believes that cash and short-term
     investments and the remainder of its credit lines are sufficient to meet
     any existing and presently anticipated cash needs. In addition, because of
     its low debt to equity ratio, the Company believes it has sufficient debt
     capacity to replace its existing revolver and provide the necessary funds
     to achieve its corporate objectives.

Factors That May Affect Future Operating Results

     Certain information of a non-historical nature contain forward-looking
     statements. Words such as "believes," "expects," "plans," "estimates" and
     variations of such words are intended to identify such forward-looking
     statements. The statements are not guaranties of future performance and are
     subject to certain risks, uncertainties or assumptions that are difficult
     to predict; therefore, the Company cautions shareholders and prospective
     investors that the following important factors, among others, could in the
     future affect the Company's actual operating results which could differ
     materially from those expressed in any forward-looking statements. The
     statements under this caption are intended to serve as cautionary
     statements within the meaning of the Private Securities Litigation Reform
     Act of 1995. The following information is not intended to limit in any way
     the characterization of other statements or information under other
     captions as cautionary statements for such purpose. The order in which such
     factors appear below should not be construed to indicate their relative
     importance or priority.

     .    Reduced growth in expenditures for dental services by private dental
          insurance plans.

     .    Accuracy of the Company's assumptions concerning future per capita
          expenditures for dental services, including assumptions as to
          population growth and the demand for preventive dental services such
          as periodontic, endodontic and orthodontic procedures.

     .    The rate of growth in demand for infection control products currently
          used for prevention of the spread of communicable diseases such as
          AIDS, hepatitis and herpes.

     .    The effects of, and changes in, U.S. and world social and economic
          conditions, monetary and fiscal conditions, laws and regulations,
          other activities of governments, agencies and similar organizations,
          trade policies and taxes, import and other charges, inflation and
          monetary fluctuations; the ability or inability of the Company to
          obtain or hedge against foreign currencies, foreign exchange rates and
          fluctuations in those rates.

     .    Ability of the Company to retain its base of customers and to increase
          its market share.

                                       11


     .    The ability of the Company to maintain satisfactory relationships with
          qualified and motivated sales personnel.

     .    Changes in economics of dentistry affecting dental practice growth and
          the demand for dental products, including the ability and willingness
          of dentists to invest in high-technology diagnostic and therapeutic
          products.

     .    The Company's ability to meet increased competition from national,
          regional and local full-service distributors and mail-order
          distributors of dental products, while maintaining current or improved
          profit margins.

     .    Continued ability of the Company to maintain satisfactory
          relationships with key vendors and the ability of the Company to
          create relationships with additional manufacturers of quality,
          innovative products.

     .    Because the cost of paper stock represents over half the cost of the
          Company's paper and printed products, future operating results may be
          subject to fluctuations in paper prices.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     There have been no material changes in market risk during the three months
     ended January 27, 2001. For additional information refer to item 7A of the
     Company's 2000 Form 10K.

                                       12


                           PART II OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K.

     (a)  Item 27 Financial Data Schedule.

     (b)  No reports on Form 8-K were filed during the quarter for which this
report is filed.

All other items under Part II have been omitted because they are inapplicable or
the answers are negative, or, in the case of legal proceedings, were previously
reported in the annual report on Form 10-K filed July 25, 2000.

                                       13


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                        PATTERSON DENTAL COMPANY
                                        (Registrant)

Dated: March 13, 2001

                                   By:  /s/ R. Stephen Armstrong
                                       -------------------------
                                        R. Stephen Armstrong
                                        Executive Vice President, Treasurer and
                                          Chief Financial Officer
                                        (Principal Financial Officer and
                                        Principal Accounting Officer)

                                       14